Ghannoum, Mahmoud A.

Ibrexafungerp Versus Placebo for Vulvovaginal Candidiasis Treatment: A Phase 3, Randomized, Controlled Superiority Trial (VANISH 303)

Schwebke, J. R., Sobel, R., Gersten, J. K., Sussman, S. A., Lederman, S. N., Jacobs, M. A., Chappell, B. T., Weinstein, D. L., Moffett, A. H., Azie, N. E., et al. (2022) · Clinical Infectious Diseases

Antifungal resistance and susceptibilityReproductive tract infections research

Cited by 82

Establishment and Use of Epidemiological Cutoff Values for Molds and Yeasts by Use of the Clinical and Laboratory Standards Institute M57 Standard

Lockhart, S. R., Ghannoum, M. A., & Alexander, B. D. (2017) · Journal of Clinical Microbiology

Antifungal resistance and susceptibilityBacterial Identification and Susceptibility Testing

Cited by 81

Evaluation of the antifungal activity of the novel Oral Glucan synthase inhibitor SCY-078, singly and in combination, for the treatment of invasive aspergillosis

Ghannoum, M., Long, L., Larkin, E. L., Isham, N., Sherif, R., Borroto-Esoda, K., Barat, S., & Angulo, D. (2018) · Antimicrobial Agents and Chemotherapy

Antifungal resistance and susceptibilityFungal and yeast genetics research

Cited by 80

Quality Control Guidelines for Amphotericin B, Itraconazole, Posaconazole, and Voriconazole Disk Diffusion Susceptibility Tests with Nonsupplemented Mueller-Hinton Agar (CLSI M51-A Document) for Nondermatophyte Filamentous Fungi

Espinel-Ingroff, A., Canton, E., Fothergill, A., Ghannoum, M., Johnson, E., Jones, R. N., Ostrosky-Zeichner, L., Schell, W., Gibbs, D. L., Wang, A., et al. (2011) · Journal of Clinical Microbiology

Antifungal resistance and susceptibilityBacterial Identification and Susceptibility Testing

Cited by 78

Update on the Pathogenesis, Virulence, and Treatment of Candida auris

Watkins, R. R., Gowen, R., Lionakis, M., & Ghannoum, M. (2022) · Pathogens and Immunity

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 68

Breakthrough C. parapsilosis and C. guilliermondii blood stream infections in allogeneic hematopoietic stem cell transplant recipients receiving long-term caspofungin therapy

Kabbara, N., Lacroix, C., Peffault de Latour, R., Socie, G., Ghannoum, M., & Ribaud, P. (2008) · Haematologica

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 61

A Randomized Phase 2 Study of VT-1161 for the Treatment of Acute Vulvovaginal Candidiasis

Brand, S. R., Sobel, J. D., Nyirjesy, P., Ghannoum, M. A., Schotzinger, R. J., & Degenhardt, T. P. (2021) · Clinical Infectious Diseases

Antifungal resistance and susceptibilityReproductive tract infections research

Cited by 61

Ibrexafungerp, a Novel Oral Triterpenoid Antifungal in Development: Overview of Antifungal Activity Against Candida glabrata

Gamal, A., Chu, S., McCormick, T. S., Borroto-Esoda, K., Angulo, D., & Ghannoum, M. A. (2021) · Frontiers in Cellular and Infection Microbiology

Antifungal resistance and susceptibilityFungal Plant Pathogen Control

Cited by 58

Efficacy and Safety of Oteseconazole in Recurrent Vulvovaginal Candidiasis

Sobel, J. D., Donders, G., Degenhardt, T., Person, K., Curelop, S., Ghannoum, M., & Brand, S. R. (2022) · NEJM Evidence

Antifungal resistance and susceptibilityReproductive tract infections research

Cited by 55

Gamma interferon protects endothelial cells from damage by Candida albicans by inhibiting endothelial cell phagocytosis

Fratti, R. A., Ghannoum, M. A., Edwards, J. E., & Filler, S. G. (1996) · Infection and Immunity

Antifungal resistance and susceptibilityFungal and yeast genetics research

Cited by 46

CD101, a novel echinocandin, possesses potent antibiofilm activity against early and mature Candida albicans biofilms

Chandra, J., & Ghannoum, M. A. (2018) · Antimicrobial Agents and Chemotherapy

Antifungal resistance and susceptibilityBacterial biofilms and quorum sensing

Cited by 36

Biofilms and beyond: Expanding echinocandin utility

Larkin, E. L., Dharmaiah, S., & Ghannoum, M. A. (2018) · Journal of Antimicrobial Chemotherapy

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 31

In Vivo Skin Colonization and Decolonization Models for Candida auris

Herrada, J., Gamal, A., Long, L., & Ghannoum, M. A. (2022) · Methods in Molecular Biology

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 7

Flucytosine: Site of Action, Mechanism of Resistance and Use in Combination Therapy

Chandra, J., Mohammad, S., & Ghannoum, M. A. (2009) · Antimicrobial Drug Resistance

Antifungal resistance and susceptibilityFungal Plant Pathogen Control

Cited by 6